The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
Visani
G
G
Stanford University Hospital, CA.
Gamberi
B
B
Greenberg
P
P
Advani
R
R
Gulati
S
S
Champlin
R
R
Hoglund
M
M
Karanes
C
C
Williams
S
S
Keating
A
A
D016026:Bone Marrow Transplantation; D004311:Double-Blind Method; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D009369:Neoplasms / Q000601:surgery; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor